OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis
Merit Cudkowicz, Stacy Lindborg, Namita Goyal, et al.
Muscle & Nerve (2021) Vol. 65, Iss. 3, pp. 291-302
Open Access | Times Cited: 71
Merit Cudkowicz, Stacy Lindborg, Namita Goyal, et al.
Muscle & Nerve (2021) Vol. 65, Iss. 3, pp. 291-302
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 256
Richard J. Mead, Ning Shan, H. Joseph Reiser, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 185-212
Open Access | Times Cited: 256
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
Vitali Maldonado, Neel Patel, Emma E. Smith, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 53
Vitali Maldonado, Neel Patel, Emma E. Smith, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 53
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO‐NMD)
Philip Van Damme, Ammar Al‐Chalabi, Peter M. Andersen, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 36
Philip Van Damme, Ammar Al‐Chalabi, Peter M. Andersen, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 36
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 36
Elżbieta Cecerska‐Heryć, Maja Pękała, Natalia Serwin, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2643-2673
Open Access | Times Cited: 36
Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series
Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Shirin Barati, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114378-114378
Open Access | Times Cited: 34
Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Shirin Barati, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114378-114378
Open Access | Times Cited: 34
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16119-16119
Open Access | Times Cited: 27
Corneliu Toader, Nicolaie Dobrin, Felix-Mircea Brehar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16119-16119
Open Access | Times Cited: 27
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects
Roisin McMackin, Peter Bede, Caroline Ingre, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 754-768
Closed Access | Times Cited: 26
Roisin McMackin, Peter Bede, Caroline Ingre, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 754-768
Closed Access | Times Cited: 26
Cell therapy in ALS: An update on preclinical and clinical studies
Francesca Sironi, Fabiola De Marchi, Letizia Mazzini, et al.
Brain Research Bulletin (2023) Vol. 194, pp. 64-81
Open Access | Times Cited: 23
Francesca Sironi, Fabiola De Marchi, Letizia Mazzini, et al.
Brain Research Bulletin (2023) Vol. 194, pp. 64-81
Open Access | Times Cited: 23
Stem cell therapeutics and gene therapy for neurologic disorders
Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00427-e00427
Open Access | Times Cited: 10
Kevin S. Chen, Emily J. Koubek, Stacey A. Sakowski, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00427-e00427
Open Access | Times Cited: 10
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
Christina N. Fournier
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1180-1192
Open Access | Times Cited: 29
Christina N. Fournier
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1180-1192
Open Access | Times Cited: 29
The 2022 yearbook of Neurorestoratology
Hongyun Huang, John R. Bach, Hari Shanker Sharma, et al.
Journal of Neurorestoratology (2023) Vol. 11, Iss. 2, pp. 100054-100054
Open Access | Times Cited: 21
Hongyun Huang, John R. Bach, Hari Shanker Sharma, et al.
Journal of Neurorestoratology (2023) Vol. 11, Iss. 2, pp. 100054-100054
Open Access | Times Cited: 21
Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS
Seung Hyun Kim, Ki‐Wook Oh, Min‐Young Noh, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 4, pp. 309-316
Open Access | Times Cited: 7
Seung Hyun Kim, Ki‐Wook Oh, Min‐Young Noh, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 4, pp. 309-316
Open Access | Times Cited: 7
Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies
Jameel M. Al-Khayri, Mithunan Ravindran, Akshatha Banadka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1391-1391
Open Access | Times Cited: 7
Jameel M. Al-Khayri, Mithunan Ravindran, Akshatha Banadka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1391-1391
Open Access | Times Cited: 7
Genetic modification and preconditioning strategies to enhance functionality of mesenchymal stromal cells: a clinical perspective
Kasra Moeinabadi‐Bidgoli, Radman Mazloomnejad, Alireza Beheshti Maal, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 6, pp. 461-478
Closed Access | Times Cited: 15
Kasra Moeinabadi‐Bidgoli, Radman Mazloomnejad, Alireza Beheshti Maal, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 6, pp. 461-478
Closed Access | Times Cited: 15
Therapeutic targeting ofALS pathways: Refocusing an incomplete picture
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies
Ahlke Heydemann, Maria Siemionow
Biomedicines (2023) Vol. 11, Iss. 3, pp. 830-830
Open Access | Times Cited: 13
Ahlke Heydemann, Maria Siemionow
Biomedicines (2023) Vol. 11, Iss. 3, pp. 830-830
Open Access | Times Cited: 13
The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
Di He, Yan Xu, Mingsheng Liu, et al.
Aging and Disease (2023) Vol. 15, Iss. 1, pp. 96-96
Open Access | Times Cited: 13
Di He, Yan Xu, Mingsheng Liu, et al.
Aging and Disease (2023) Vol. 15, Iss. 1, pp. 96-96
Open Access | Times Cited: 13
Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression
Lucas Vu, Krystine Garcia‐Mansfield, Antonio Pompeiano, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 2025-2042
Open Access | Times Cited: 13
Lucas Vu, Krystine Garcia‐Mansfield, Antonio Pompeiano, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 2025-2042
Open Access | Times Cited: 13
Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice
Albert C. Ludolph, Philippe Corcia, Claude Desnuelle, et al.
Muscle & Nerve (2024) Vol. 70, Iss. 1, pp. 36-41
Closed Access | Times Cited: 5
Albert C. Ludolph, Philippe Corcia, Claude Desnuelle, et al.
Muscle & Nerve (2024) Vol. 70, Iss. 1, pp. 36-41
Closed Access | Times Cited: 5
Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas
Mohammed Khamaysa, Pierre‐François Pradat
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1601-1601
Open Access | Times Cited: 22
Mohammed Khamaysa, Pierre‐François Pradat
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1601-1601
Open Access | Times Cited: 22
Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis
Ario Mirian, Alexander J. Moszczynski, Serena Soleimani, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Ario Mirian, Alexander J. Moszczynski, Serena Soleimani, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
